Edgewise Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| KOCH KEVIN | President and CEO | Option Exercise | 10,416 | — | — | 10,416 | May 2, 2023 |
| MOORE JOHN R | General Counsel | Sale | 1,897 | $8.90 | $16,883 | 6,565 | May 1, 2023 |
| Carruthers R Michael | Chief Financial Officer | Sale | 1,336 | $8.90 | $11,890 | 16,126 | May 1, 2023 |
| Russell Alan J | Chief Scientific Officer | Sale | 1,602 | $8.90 | $14,258 | 176,191 | May 1, 2023 |
| Donovan Joanne M. | CMO | Sale | 3,254 | $8.90 | $28,961 | 9,960 | May 1, 2023 |
| MOORE JOHN R | General Counsel | Option Exercise | 4,730 | $1.93 | $9,129 | 7,730 | Oct 3, 2022 |
| Thompson Peter A. | — | Purchase | 484,496 | $10.32 | $4,999,999 | 13,981,952 | Sep 16, 2022 |
| OrbiMed Genesis GP LLC | — | Purchase | 484,496 | $10.32 | $4,999,999 | 13,981,952 | Sep 16, 2022 |
| Novo Holdings A/S | — | Purchase | 484,496 | $10.32 | $4,999,999 | 6,071,703 | Sep 14, 2022 |
| MOORE JOHN R | General Counsel | Sale | 2,351 | $10.99 | $25,837 | 3,000 | Sep 6, 2022 |
| MOORE JOHN R | General Counsel | Option Exercise | 4,730 | $1.93 | $9,129 | 7,730 | Aug 3, 2022 |
| MOORE JOHN R | General Counsel | Option Exercise | 1,046 | $1.93 | $2,019 | 4,046 | Jul 5, 2022 |
| MOORE JOHN R | General Counsel | Sale | 31,078 | $7.29 | $226,559 | 3,000 | Jun 21, 2022 |
| MOORE JOHN R | General Counsel | Sale | 3,628 | $6.02 | $21,841 | 3,000 | Jun 13, 2022 |
| MOORE JOHN R | General Counsel | Option Exercise | 7,615 | $0.71 | $5,407 | 10,615 | Jun 8, 2022 |
| MOORE JOHN R | General Counsel | Option Exercise | 13,934 | $1.93 | $26,893 | 16,934 | Jun 7, 2022 |
| Carruthers R Michael | Chief Financial Officer | Option Exercise | 9,000 | $0.71 | $6,390 | 12,000 | May 23, 2022 |
| OrbiMed Capital GP VI LLC | — | Purchase | 138,000 | $7.21 | $994,980 | 13,497,456 | May 18, 2022 |
| Thompson Peter A. | — | Purchase | 138,000 | $7.21 | $994,980 | 13,497,456 | May 18, 2022 |
| MOORE JOHN R | General Counsel | Sale | 10,800 | $7.42 | $80,136 | 3,000 | May 16, 2022 |
| ROOT JONATHAN D | — | Other | 3,473,543 | — | — | — | Feb 25, 2022 |
| MOORE JOHN R | General Counsel | Option Exercise | 5,400 | $0.71 | $3,834 | 12,362 | Jan 21, 2022 |
| MOORE JOHN R | General Counsel | Option Exercise | 5,400 | $0.71 | $3,834 | 6,962 | Dec 28, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 38 | $19.61 | $745 | — | Nov 15, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 12,712 | $20.30 | $258,054 | 40,643 | Nov 10, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 6 | $20.70 | $124 | 92,272 | Nov 4, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 1,119 | $19.42 | $21,731 | 99,670 | Nov 3, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 126 | $18.00 | $2,268 | 143,842 | Oct 14, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 1,270 | $18.02 | $22,885 | 151,024 | Oct 11, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 13,018 | $18.56 | $241,614 | 158,196 | Oct 6, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 100 | $18.00 | $1,800 | 178,726 | Oct 1, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 14,610 | $17.30 | $252,753 | 190,944 | Sep 29, 2021 |
| Russell Alan J | Chief Scientific Officer | Sale | 5,072 | $19.42 | $98,498 | 237,265 | Sep 27, 2021 |
| ROOT JONATHAN D | — | C | 3,473,543 | — | — | 3,473,543 | Mar 30, 2021 |
| Thompson Peter A. | — | Purchase | 312,500 | $16.00 | $5,000,000 | 13,359,456 | Mar 30, 2021 |
| ORBIMED ADVISORS LLC | — | Purchase | 46,875 | $16.00 | $750,000 | 319,599 | Mar 30, 2021 |
| Novo Holdings A/S | — | Purchase | 625,000 | $16.00 | $10,000,000 | 5,587,207 | Mar 30, 2021 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | — | C | 681,812 | — | — | 681,812 | Mar 30, 2021 |
| Deerfield Private Design Fund IV, L.P. | — | Purchase | 625,000 | $16.00 | $10,000,000 | 3,933,137 | Mar 30, 2021 |